A detailed history of Jpmorgan Chase & CO transactions in Orasure Technologies Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 801,717 shares of OSUR stock, worth $3.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
801,717
Previous 275,980 190.5%
Holding current value
$3.38 Million
Previous $1.7 Million 101.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.2 - $6.18 $2.21 Million - $3.25 Million
525,737 Added 190.5%
801,717 $3.42 Million
Q1 2024

May 10, 2024

BUY
$6.08 - $8.28 $636,253 - $866,477
104,647 Added 61.08%
275,980 $1.7 Million
Q4 2023

Feb 12, 2024

SELL
$5.13 - $8.35 $588,446 - $957,803
-114,707 Reduced 40.1%
171,333 $1.4 Million
Q3 2023

Nov 14, 2023

BUY
$4.4 - $6.91 $510,681 - $802,002
116,064 Added 68.28%
286,040 $1.7 Million
Q2 2023

Aug 11, 2023

BUY
$4.88 - $7.39 $201,592 - $305,280
41,310 Added 32.11%
169,976 $851,000
Q1 2023

May 18, 2023

BUY
$4.66 - $6.52 $256,248 - $358,528
54,989 Added 74.64%
128,666 $778,000
Q1 2023

May 11, 2023

SELL
$4.66 - $6.52 $138,318 - $193,526
-29,682 Reduced 28.72%
73,677 $445,000
Q4 2022

Feb 13, 2023

BUY
$3.7 - $5.29 $35,745 - $51,106
9,661 Added 10.31%
103,359 $498,000
Q3 2022

Nov 14, 2022

BUY
$2.72 - $4.61 $2,012 - $3,411
740 Added 0.8%
93,698 $355,000
Q2 2022

Aug 11, 2022

BUY
$2.71 - $7.12 $69,343 - $182,186
25,588 Added 37.98%
92,958 $252,000
Q1 2022

May 11, 2022

BUY
$6.62 - $9.33 $82,783 - $116,671
12,505 Added 22.79%
67,370 $457,000
Q4 2021

Feb 10, 2022

BUY
$8.3 - $11.29 $37,399 - $50,872
4,506 Added 8.95%
54,865 $477,000
Q3 2021

Nov 12, 2021

BUY
$9.73 - $13.38 $489,993 - $673,803
50,359 New
50,359 $569,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $306M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.